Gewinn & Umsatz News zur MODERNA Aktie

 

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Zugegeben: Die Erwartungen der Wall Street an den Quartalsbericht des Corona-Impfstoff-Entwicklers waren niedrig. Sehr niedrig. Dennoch konnte Moderna die Prognosen deutlich übertreffen. Die Aktie gewinnt daraufhin knapp zehn Prozent und kann sich damit von den jüngsten Tiefständen wieder nach oben lösen....

Moderna Iny. shares rose after the company posted a narrower third-quarter loss than Wall Street expected, a sign that its cost-cutting measures are helping offset the decline of its Covid business....

Das Biotechkonzern Moderna hat Anlegern am Donnertag vor Handelsbeginn an den US-Börsen seine Drittquartalsbilanz präsentiert....

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Moderna swung to a loss and logged lower sales in the third quarter as it works to expand its offerings amid weakening demand for its Covid-19 vaccine....

The American Academy Of Pediatrics: Mining Children For Profit Authored by David Bell via The Brownstone Institute, American healthcare is currently providing us with an excellent lesson in what capitalism looks like in the absence of a moral framework. The biggest losers are America's children... The Union Profiting from Childhood Sickness The American Academy of Pediatrics (AAP), the major professional association of North American pediatricians, has overseen the rising rates of chronic illness and medicating of American children over recent decades. With 67,000 members in the United States, Canada, and Mexico, AAP distinguished itself during Covid-19 for its strident insistence that children's faces should be covered and they should be injected with modified RNA vaccines, despite knowing from early 2020 that severe Covid-19 was very rare in healthy children.  Funded by sources including Moderna, Merck, Sanofi, GSK, Eli Lilly, and other pharmaceutical companies, the AAP's members ...

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

WASHINGTON (dpa-AFX) - Moderna, Inc (MRNA) announced Loss for second quarter that decreased from the same period last year and beat the Street estimates.The company's earnings came in at -$825 mil......

Am Freitagnachmittag hat der Biotechkonzern Moderna seine Bücher geöffnet und Anlegern einen Einblick in die Geschäftsentwicklung im zweiten Quartal gewährt....

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Moderna also lost less than Wall Street analysts were expecting for the second quarter and posted revenue that topped estimates. ...

Diese 10 Fakten dürften heute für Bewegung an den Märkten sorgen....

In a memo to employees, Moderna CEO Stephane Bancel said the company expects to have fewer than 5,000 workers by the end of the year....

Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in its losses....

WASHINGTON (dpa-AFX) - Biotechnology company Moderna, Inc. (MRNA) announced Monday positive results from a Phase 3 efficacy study evaluating the relative vaccine efficacy (rVE) against influenza i......

The phase three study data clears the path forward for Moderna's combination jab targeting Covid-19 and influenza....

As Moderna has significantly lagged behind the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock's prospects....

Mit Spannung hatten Anleger auf die Moderna-Bilanz gewartet. Am Donnerstag öffnete das Unternehmen seine Bücher....

WASHINGTON (dpa-AFX) - Moderna, Inc (MRNA) announced Loss for first quarter that decreased from last year and beat the Street estimates.The company's bottom line came in at -$971 million, or -$2.5......